Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ear10 Inhibitors

Ear10, a pivotal gene in cellular function, exhibits a multifaceted role encompassing ribonuclease activity, chemotaxis, and innate immune responses in mucosal tissues. Its functional involvement in the extracellular space underscores its significance in orchestrating diverse physiological processes. The predicted orthology to human genes, notably RNASE3, suggests conserved functionality and underscores the potential relevance of findings related to Ear10 in the broader context of mammalian biology. The intricacies of Ear10 function are further underscored by its predicted roles in chemotaxis, hinting at its involvement in cellular migration, and in the innate immune response within mucosal environments, pointing towards its potential role in host defense mechanisms.

Understanding the general mechanisms of Ear10 inhibition unveils a spectrum of intricate cellular pathways targeted by specific chemical entities. These inhibitors act through diverse signaling cascades, modulating the expression and activity of Ear10 indirectly. The inhibition is achieved by disrupting key pathways such as the B-cell receptor signaling pathway, NF-κB pathway, DNA damage response, MAPK pathway, PI3K/AKT pathway, and BET pathway. These pathways represent interconnected cellular networks, and the inhibitors exert their effects by influencing downstream effectors, altering gene expression patterns, and perturbing the delicate balance of cellular signaling. This nuanced approach to inhibition reflects the complexity of cellular regulation and provides a glimpse into the potential regulatory mechanisms governing Ear10 function. Importantly, these inhibitors, through their specific actions on various pathways, offer valuable tools for scientific investigations aiming to dissect the intricate roles of Ear10 in cellular processes.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

Trametinib, a MEK inhibitor, modulates the MAPK pathway, influencing Ear10 indirectly by altering signaling cascades and gene expression within the intricate network of cellular responses.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib, a BCR-ABL inhibitor, indirectly inhibits Ear10 by disrupting the BCR-ABL signaling pathway, modulating downstream kinases, and influencing gene expression in relevant cellular contexts.